Mesoblast believes these additional data will provide a link between the RYONCIL product that
was used in the Phase 3 trial MSB-GVHD001 for the pediatric indication to the RYONCIL product
which will be used in a future trial for the adult indication.
Ok - sorry - not following as closely as the 40 hour a week emergency doctor- is this a stitch up?
The adult potency assay is based on the kid assay that met its endpoint/ here is the data
no wonder he is chirpy
Reg
Mesoblast believes these additional data will provide a link...
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.030(3.19%) |
Mkt cap ! $1.110B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 98.0¢ | 92.0¢ | $3.342M | 3.477M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33313 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 73982 | 2 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |